SIRIUS NEOSIGHT, a company specializing in the isolation of Circulating Tumor Cells (CTCs) and the development of functional tests for predicting therapeutic response in oncology, has completed a €4.4 million funding round. The financing round was secured from GO CAPITAL via its GOCA3 seed fund, DEMETER through the FAIM (Fonds d’Amorçage Industriel Métropolitain) Lyon/Saint-Etienne fund,
Category: Actualités Anglais
• Cerea Partners and Demeter Investment Managers are excited to announce the signing of a major strategic agreement for a merger of equals. This union will give rise to Demea Invest, a leading player in private equity and private debt investments in startups, SMEs, and mid-sized companies, driven by an ambitious vision. • Through this
Demeter, via the Climate Infrastructure Fund (art 9 SFDR), is proud to announce its investment in ZE Energy, alongside Amundi Transition Énergétique and Sorégies, a historical shareholder reaffirming its confidence in the project. Founded in 2019, ZE Energy has developed an innovative solution for hybrid solar power plants, combining photovoltaics and energy storage, tailored for the